What is the current Price Target for the Astria Therapeutics stock?

The average Astria Therapeutics target price is $28.56. This is 335.37% higher than the current stock price. The highest price target is 652.29%, the lowest is 146.34%. 10 Analysts have issued a price target Astria Therapeutics 2026 .

How high will the Astria Therapeutics stock rise?

No reliable answer can be given as to how high the Astria Therapeutics stock will rise. The performance of stocks, including the Astria Therapeutics stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Astria Therapeutics stock today?

The performance of Astria Therapeutics stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Astria Therapeutics stock fall?

The decline in Astria Therapeutics stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Astria Therapeutics Forecast, price target & analysts

$6.56

5.20% yesterday

NYSE, Aug 01, 10:00 pm CET

ISIN

US04635X1028

Symbol

ATXS

Reports

Quarter | Annual

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Astria Therapeutics Target price 2025 - Analyst rating & recommendation

Astria Therapeutics Classifications & Recommendation:

Buy

93%

Hold

Astria Therapeutics Price Target

Target Price	$28.56
Price	$6.56
Potential	335.37% register free of charge
Number of Estimates	10

	10 Analysts have issued a price target Astria Therapeutics 2026 . The average Astria Therapeutics target price is $28.56. This is 335.37% register free of charge higher than the current stock price. The highest price target is $49.35 652.29% register free of charge , the lowest is $16.16 146.34% register free of charge .
	A rating was issued by 15 analysts: 14 Analysts recommend Astria Therapeutics to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Astria Therapeutics stock has an average upside potential 2026 of 335.37% register free of charge . Most analysts recommend the Astria Therapeutics stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-1.68	-2.25
	30.58%	33.93%
P/E		negative

11 Analysts have issued a Astria Therapeutics forecast for earnings per share. The average Astria Therapeutics EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-1.68	30.58%
2025	$-2.25 33.93% Unlock
2026	$-2.37 5.33% Unlock
2027	$-2.47 4.22% Unlock
2028	$-1.65 33.20% Unlock
2029	$-0.53 67.88% Unlock
2030	$0.51 196.23% Unlock
2031	$2.30 350.98% Unlock
2032	$3.75 63.04% Unlock

Current	-3.68	49.09%
2025	-3.07 16.60% Unlock
2026	-2.92 4.89% Unlock
2027	-2.80 4.11% Unlock
2028	-4.18 49.29% Unlock
2029	-12.96 210.05% Unlock
2030	13.48 204.01% Unlock
2031	3.02 77.60% Unlock
2032	1.85 38.74% Unlock

Astria Therapeutics...

Current Astria Therapeutics Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 13 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	May 14 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	Apr 29 2025
Wedbush	Locked ➜ Locked	Locked	Mar 12 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 11 2025
Citizens Capital Markets	Locked ➜ Locked	Locked	Mar 03 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Feb 27 2025

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 13 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	May 14 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	Apr 29 2025
Locked Wedbush: Locked ➜ Locked	Mar 12 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 11 2025
Locked Citizens Capital Markets: Locked ➜ Locked	Mar 03 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Feb 27 2025

Discover more stocks with a high price target

BioNTech SE - ADR 30.66%

Alibaba Group Holding Ltd 27.33%

MongoDB 26.94%

Deutsche Telekom 24.51%

Infineon 22.22%

Tencent Holdings Ltd. 21.83%

PayPal 21.59%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now